Welcome to Molecular Psychiatry

Molecular Psychiatry publishes definitive, high-impact work that elucidates key issues in psychiatry and related fields. The emphasis is on bringing together in one journal the best pre-clinical and clinical research, including research at the cellular, molecular, integrative, epidemiological, translational, clinical, imaging, psychopharmacology, and treatment outcome levels. Cutting-edge articles are highly cited in the fields of psychiatry, psychology, neuroscience, biochemistry & molecular biology.


*** Announcing Molecular Psychiatry Open ***

Molecular Psychiatry now offers authors the option to publish their articles with immediate open access upon publication. Open access articles will also be deposited on PubMed Central at the time of publication and will be freely available immediately. Find out more from the press release or our FAQs page.

******



About the cover Free online issue

Volume 14, No 12
December 2009

ISSN: 1359-4184
EISSN: 1476-5578

Impact Factor 12.537*
2/101 Psychiatry
8/219 Neuroscience
9/276 Biochemistry & Molecular Biology

Editor:
Julio Licinio, MD

*2008 Journal Citation Report (Thomson Reuters, 2009)

NEWS

Visit the Molecular Psychiatry Blog and keep up with the latest research in the field!

New blood biomarker research could make it possible to identify psychotic symptoms through clinical laboratory tests. Furthering prior research into mood disorder biomarkers, Kurian et al. provide proof of principle for identifying biomarkers for hallucinations and delusions. This research could lead to objective assessments and treatments of mental illnesses.

One in eight US adults smoke a pack of cigarettes a day and most of the risk of habitual heavy smoking (nicotine addiction) is genetic. This paper studied DNA samples from 14,000 people and showed the most important genetic predictors of nicotine addiction are variants in genes that produce the brain proteins to which nicotine binds.

Extra navigation

26 November 2009

ADVERTISEMENT